Michael T C Poon
Overview
Explore the profile of Michael T C Poon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wu H, Wang M, Wu J, Francis F, Chang Y, Shavick A, et al.
NPJ Digit Med
. 2022 Dec;
5(1):186.
PMID: 36544046
Much of the knowledge and information needed for enabling high-quality clinical research is stored in free-text format. Natural language processing (NLP) has been used to extract information from these sources...
12.
Woodfield J, Hoeritzauer I, Jamjoom A, Jung J, Lammy S, Pronin S, et al.
Lancet Reg Health Eur
. 2022 Nov;
24:100545.
PMID: 36426378
Background: Cauda equina syndrome (CES) results from nerve root compression in the lumbosacral spine, usually due to a prolapsed intervertebral disc. Evidence for management of CES is limited by its...
13.
Woodfield J, Lammy S, Jamjoom A, Fadelalla M, Copley P, Arora M, et al.
Neuroepidemiology
. 2022 Oct;
56(6):460-468.
PMID: 36315989
Introduction: Cauda equina syndrome (CES) has significant medical, social, and legal consequences. Understanding the number of people presenting with CES and their demographic features is essential for planning healthcare services...
14.
Loan J, Tominey S, Baweja K, Woodfield J, Chambers T, Haley M, et al.
Stroke Vasc Neurol
. 2022 Sep;
8(3):207-216.
PMID: 36150732
Background: Hyponatraemia often occurs after subarachnoid haemorrhage (SAH). However, its clinical significance and optimal management are uncertain. We audited the screening, investigation and management of hyponatraemia after SAH. Methods: We...
15.
Gillespie C, Bligh E, Poon M, Solomou G, Islim A, Mustafa M, et al.
BMJ Open
. 2022 Sep;
12(9):e063043.
PMID: 36100297
Introduction: Glioblastoma is the most common malignant primary brain tumour with a median overall survival of 12-15 months (range 6-17 months), even with maximal treatment involving debulking neurosurgery and adjuvant...
16.
Solomou G, Gharooni A, Patel W, Gillespie C, Gough M, Venkatesh A, et al.
BMJ Open
. 2022 Jul;
12(7):e056059.
PMID: 35868820
Introduction: 5-aminolevulinic acid (5-ALA) is a proagent developed for fluorescent-guided surgery for high-grade glioma patients associated with a significant increase in resection conferring survival. 5-ALA was shown to penetrate the...
17.
Innes C, Henshall D, Wilson B, Poon M, Morley S, Ritchie S
Diabet Med
. 2022 Jun;
39(10):e14902.
PMID: 35716029
Background: The Dose Adjustment for Normal Eating (DAFNE) course teaches insulin dose adjustment to match dietary carbohydrates and improve glycaemic control in participants with type 1 diabetes mellitus (T1DM). We...
18.
Poon M, Brennan P, Jin K, Sudlow C, Figueroa J
Neuro Oncol
. 2022 Feb;
24(6):1032-1033.
PMID: 35191965
No abstract available.
19.
Park J, Ooi S, Gillespie C, Bandyopadhyay S, Chowdhury Y, Solomou G, et al.
Acta Neurochir (Wien)
. 2022 Jan;
164(4):937-946.
PMID: 35039958
Collaboration and successful teamworking are important components of clinical practise, and these skills should be cultivated early in medical school. The breadth of current medical school curricula means that students...
20.
Poon M, Keni S, Vimalan V, Ip C, Smith C, Erridge S, et al.
Neurooncol Adv
. 2022 Jan;
3(1):vdab171.
PMID: 34988453
Background: methylation in glioblastoma predicts response to temozolomide but dichotomizing methylation status may mask the true prognostic value of quantitative methylation. This study evaluated whether extent of methylation interacts with...